KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

UiPath (PATH) Cash & Equivalents (2021 - 2026)

UiPath (PATH) has disclosed Cash & Equivalents for 5 consecutive years, with $743.7 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Cash & Equivalents fell 3.87% year-over-year to $743.7 million, compared with a TTM value of $743.7 million through Oct 2025, down 3.87%, and an annual FY2025 reading of $879.2 million, down 17.19% over the prior year.
  • Cash & Equivalents was $743.7 million for Q4 2025 at UiPath, up from $628.6 million in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $1.8 billion in Q3 2021 and bottomed at $357.7 million in Q1 2021.
  • Average Cash & Equivalents over 5 years is $1.2 billion, with a median of $1.1 billion recorded in 2023.
  • The sharpest move saw Cash & Equivalents skyrocketed 394.48% in 2022, then tumbled 38.89% in 2025.
  • Year by year, Cash & Equivalents stood at $1.8 billion in 2021, then fell by 18.31% to $1.5 billion in 2022, then plummeted by 30.88% to $1.0 billion in 2023, then fell by 22.87% to $773.6 million in 2024, then fell by 3.87% to $743.7 million in 2025.
  • Business Quant data shows Cash & Equivalents for PATH at $743.7 million in Q4 2025, $628.6 million in Q3 2025, and $700.6 million in Q2 2025.